Ligand: Buy This Pharma Royalty Aggregator To Generate Growth In Your PortfolioSeeking Alpha • 04/30/24
Wall Street Analysts Predict a 45.56% Upside in Ligand (LGND): Here's What You Should KnowZacks Investment Research • 04/17/24
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures ConferenceBusiness Wire • 04/08/24
Ligand Pharmaceuticals (LGND) Stock Dips While Market Gains: Key FactsZacks Investment Research • 04/05/24
Wall Street Analysts Think Ligand (LGND) Is a Good Investment: Is It?Zacks Investment Research • 04/04/24
Investors Heavily Search Ligand Pharmaceuticals Incorporated (LGND): Here is What You Need to KnowZacks Investment Research • 04/04/24
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™Business Wire • 04/03/24
Ligand Pharmaceuticals (LGND) Ascends While Market Falls: Some Facts to NoteZacks Investment Research • 04/01/24
Ligand Pharmaceuticals (LGND) Falls More Steeply Than Broader Market: What Investors Need to KnowZacks Investment Research • 03/26/24
Here is What to Know Beyond Why Ligand Pharmaceuticals Incorporated (LGND) is a Trending StockZacks Investment Research • 03/21/24
Ligand Pharmaceuticals (LGND) Exceeds Market Returns: Some Facts to ConsiderZacks Investment Research • 03/20/24
Ligand (LGND) Is Considered a Good Investment by Brokers: Is That True?Zacks Investment Research • 03/19/24
Ligand Pharmaceuticals (LGND) Declines More Than Market: Some Information for InvestorsZacks Investment Research • 03/14/24
Is Trending Stock Ligand Pharmaceuticals Incorporated (LGND) a Buy Now?Zacks Investment Research • 03/07/24
Ligand Pharmaceuticals to Present at Barclays 26th Annual Global Healthcare ConferenceBusiness Wire • 03/05/24
Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire • 03/04/24
Wall Street Analysts See Ligand (LGND) as a Buy: Should You Invest?Zacks Investment Research • 02/29/24